|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Luteinizing Hormone ELISA Assay | Angiotensinogen Total ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | sAPP Beta-w (Highly Sensitive) ELISA Assay | Triiodothyronine (Free) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB19104 | 27412 | 27600 | 27732 | IB79136 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the quantitative determination of LH in human serum or plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Angiotensinogen ELISA in serum, EDTA-plasma, urine, or cell culture media. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Solid phase sandwich ELISA for the determination human sAPPß-w in EDTA plasma, cerebrospinal fluids and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme immunoassay (ELISA) for the quantitative determination of Free Triiodothyronine (fT3) concentration in human serum. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | LH | Anti-Bevacizumab (Avastin®) | Metanephrine / Normetanephrine | Bordetella pertussis IgM | Amyloid Beta (1-42) |
| Sample Type | Serum, Blood Plasma | Serum and plasma. | Urine | Serum, Blood Plasma | Blood Plasma, CSF, Serum, Cell Culture Media, Extract from Brain Tissue |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 5 - 200 mlU/mL | 0.31 to 20.00 ng/mL | 1.56 to 100.0 ng/mL | 0.78 to 50 ng/mL | 0.9 to 19.0 pg/mL |
| Sensitivity | Inquire | 40 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 89.19 % (95% confidence interval: 74.58% - 96.97%) | 4.03 pg/mL |
| Assay Time | 1 hr 15 mins (incubation) | 2 hrs (incubation) | 2 hours (incubation) | Overnight + 1 hr (incubation) | 1 hr 20 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |